Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study

Background: The incidence and global burden of inflammatory bowel disease (IBD) have steadily increased in the past few decades. Improved methods to stratify risk and predict disease-related outcomes are required for IBD. Aim: The aim of this study was to develop and validate a machine learning (ML)...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Youn I, Park, Sung Jin, Chung, Jun-Won, Kim, Kyoung Oh, Cho, Jae Hee, Kim, Young Jae, Lee, Kang Yoon, Kim, Kwang Gi, Park, Dong Kyun, Kim, Yoon Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693158/
https://www.ncbi.nlm.nih.gov/pubmed/33114505
http://dx.doi.org/10.3390/jcm9113427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693158/
https://www.ncbi.nlm.nih.gov/pubmed/33114505
http://dx.doi.org/10.3390/jcm9113427

Ejemplares similares